Cargando…
Targeting potential drivers of COVID-19: Neutrophil extracellular traps
Coronavirus disease 2019 (COVID-19) is a novel, viral-induced respiratory disease that in ∼10–15% of patients progresses to acute respiratory distress syndrome (ARDS) triggered by a cytokine storm. In this Perspective, autopsy results and literature are presented supporting the hypothesis that a lit...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161085/ https://www.ncbi.nlm.nih.gov/pubmed/32302401 http://dx.doi.org/10.1084/jem.20200652 |
_version_ | 1783522885913018368 |
---|---|
author | Barnes, Betsy J. Adrover, Jose M. Baxter-Stoltzfus, Amelia Borczuk, Alain Cools-Lartigue, Jonathan Crawford, James M. Daßler-Plenker, Juliane Guerci, Philippe Huynh, Caroline Knight, Jason S. Loda, Massimo Looney, Mark R. McAllister, Florencia Rayes, Roni Renaud, Stephane Rousseau, Simon Salvatore, Steven Schwartz, Robert E. Spicer, Jonathan D. Yost, Christian C. Weber, Andrew Zuo, Yu Egeblad, Mikala |
author_facet | Barnes, Betsy J. Adrover, Jose M. Baxter-Stoltzfus, Amelia Borczuk, Alain Cools-Lartigue, Jonathan Crawford, James M. Daßler-Plenker, Juliane Guerci, Philippe Huynh, Caroline Knight, Jason S. Loda, Massimo Looney, Mark R. McAllister, Florencia Rayes, Roni Renaud, Stephane Rousseau, Simon Salvatore, Steven Schwartz, Robert E. Spicer, Jonathan D. Yost, Christian C. Weber, Andrew Zuo, Yu Egeblad, Mikala |
author_sort | Barnes, Betsy J. |
collection | PubMed |
description | Coronavirus disease 2019 (COVID-19) is a novel, viral-induced respiratory disease that in ∼10–15% of patients progresses to acute respiratory distress syndrome (ARDS) triggered by a cytokine storm. In this Perspective, autopsy results and literature are presented supporting the hypothesis that a little known yet powerful function of neutrophils—the ability to form neutrophil extracellular traps (NETs)—may contribute to organ damage and mortality in COVID-19. We show lung infiltration of neutrophils in an autopsy specimen from a patient who succumbed to COVID-19. We discuss prior reports linking aberrant NET formation to pulmonary diseases, thrombosis, mucous secretions in the airways, and cytokine production. If our hypothesis is correct, targeting NETs directly and/or indirectly with existing drugs may reduce the clinical severity of COVID-19. |
format | Online Article Text |
id | pubmed-7161085 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-71610852020-04-21 Targeting potential drivers of COVID-19: Neutrophil extracellular traps Barnes, Betsy J. Adrover, Jose M. Baxter-Stoltzfus, Amelia Borczuk, Alain Cools-Lartigue, Jonathan Crawford, James M. Daßler-Plenker, Juliane Guerci, Philippe Huynh, Caroline Knight, Jason S. Loda, Massimo Looney, Mark R. McAllister, Florencia Rayes, Roni Renaud, Stephane Rousseau, Simon Salvatore, Steven Schwartz, Robert E. Spicer, Jonathan D. Yost, Christian C. Weber, Andrew Zuo, Yu Egeblad, Mikala J Exp Med Perspective Coronavirus disease 2019 (COVID-19) is a novel, viral-induced respiratory disease that in ∼10–15% of patients progresses to acute respiratory distress syndrome (ARDS) triggered by a cytokine storm. In this Perspective, autopsy results and literature are presented supporting the hypothesis that a little known yet powerful function of neutrophils—the ability to form neutrophil extracellular traps (NETs)—may contribute to organ damage and mortality in COVID-19. We show lung infiltration of neutrophils in an autopsy specimen from a patient who succumbed to COVID-19. We discuss prior reports linking aberrant NET formation to pulmonary diseases, thrombosis, mucous secretions in the airways, and cytokine production. If our hypothesis is correct, targeting NETs directly and/or indirectly with existing drugs may reduce the clinical severity of COVID-19. Rockefeller University Press 2020-04-16 /pmc/articles/PMC7161085/ /pubmed/32302401 http://dx.doi.org/10.1084/jem.20200652 Text en © 2020 Barnes et al. http://www.rupress.org/terms/https://creativecommons.org/licenses/by-nc-sa/4.0/This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Perspective Barnes, Betsy J. Adrover, Jose M. Baxter-Stoltzfus, Amelia Borczuk, Alain Cools-Lartigue, Jonathan Crawford, James M. Daßler-Plenker, Juliane Guerci, Philippe Huynh, Caroline Knight, Jason S. Loda, Massimo Looney, Mark R. McAllister, Florencia Rayes, Roni Renaud, Stephane Rousseau, Simon Salvatore, Steven Schwartz, Robert E. Spicer, Jonathan D. Yost, Christian C. Weber, Andrew Zuo, Yu Egeblad, Mikala Targeting potential drivers of COVID-19: Neutrophil extracellular traps |
title | Targeting potential drivers of COVID-19: Neutrophil extracellular traps |
title_full | Targeting potential drivers of COVID-19: Neutrophil extracellular traps |
title_fullStr | Targeting potential drivers of COVID-19: Neutrophil extracellular traps |
title_full_unstemmed | Targeting potential drivers of COVID-19: Neutrophil extracellular traps |
title_short | Targeting potential drivers of COVID-19: Neutrophil extracellular traps |
title_sort | targeting potential drivers of covid-19: neutrophil extracellular traps |
topic | Perspective |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161085/ https://www.ncbi.nlm.nih.gov/pubmed/32302401 http://dx.doi.org/10.1084/jem.20200652 |
work_keys_str_mv | AT barnesbetsyj targetingpotentialdriversofcovid19neutrophilextracellulartraps AT adroverjosem targetingpotentialdriversofcovid19neutrophilextracellulartraps AT baxterstoltzfusamelia targetingpotentialdriversofcovid19neutrophilextracellulartraps AT borczukalain targetingpotentialdriversofcovid19neutrophilextracellulartraps AT coolslartiguejonathan targetingpotentialdriversofcovid19neutrophilextracellulartraps AT crawfordjamesm targetingpotentialdriversofcovid19neutrophilextracellulartraps AT daßlerplenkerjuliane targetingpotentialdriversofcovid19neutrophilextracellulartraps AT guerciphilippe targetingpotentialdriversofcovid19neutrophilextracellulartraps AT huynhcaroline targetingpotentialdriversofcovid19neutrophilextracellulartraps AT knightjasons targetingpotentialdriversofcovid19neutrophilextracellulartraps AT lodamassimo targetingpotentialdriversofcovid19neutrophilextracellulartraps AT looneymarkr targetingpotentialdriversofcovid19neutrophilextracellulartraps AT mcallisterflorencia targetingpotentialdriversofcovid19neutrophilextracellulartraps AT rayesroni targetingpotentialdriversofcovid19neutrophilextracellulartraps AT renaudstephane targetingpotentialdriversofcovid19neutrophilextracellulartraps AT rousseausimon targetingpotentialdriversofcovid19neutrophilextracellulartraps AT salvatoresteven targetingpotentialdriversofcovid19neutrophilextracellulartraps AT schwartzroberte targetingpotentialdriversofcovid19neutrophilextracellulartraps AT spicerjonathand targetingpotentialdriversofcovid19neutrophilextracellulartraps AT yostchristianc targetingpotentialdriversofcovid19neutrophilextracellulartraps AT weberandrew targetingpotentialdriversofcovid19neutrophilextracellulartraps AT zuoyu targetingpotentialdriversofcovid19neutrophilextracellulartraps AT egebladmikala targetingpotentialdriversofcovid19neutrophilextracellulartraps |